Trials / Completed
CompletedNCT03451526
A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,929 (actual)
- Sponsor
- Tang-Du Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The trial was designed to compare the effectiveness of radical resections of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies in the patients with N2 non-small cell lung cancer
Detailed description
The trial is a multi-centre real-world non-interventional observational study. The Chinese patients with N2 non-small cell lung cancer enrolled from 2014 to 2017 who received radical resections of lung cancer and adjuvant chemotherapies will be included in the study and the study data on patient demographic/tumor biological characteristics and clinical treatment will be collected to evaluate compare effectiveness of radical resection of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies after surgeries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Surgeries | Surgeries plus adjuvant chemotherapies or perioperative chemotherapies |
Timeline
- Start date
- 2017-12-01
- Primary completion
- 2017-12-01
- Completion
- 2018-03-30
- First posted
- 2018-03-01
- Last updated
- 2018-05-21
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03451526. Inclusion in this directory is not an endorsement.